{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:57:00Z","timestamp":1786201020893,"version":"build-2736575974"},"reference-count":31,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"DNA Chip Research Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Genetic panel tests require sufficient tissue samples, and therefore, cannot always be performed. Although collecting cytological specimens is easier than tissue collection, there are no validation studies on the diagnostic accuracy of lung cancer gene panel tests using cytology samples. Methods: Using an amplicon-based high-sensitivity next-generation sequencing panel test capable of measuring eight druggable genes, we prospectively enrolled consecutive patients who underwent diagnostic procedures. We evaluated the analysis accuracy rate, nucleic acid yield, and the quality of cytological specimens under brushing, needle aspiration, and pleural effusion. We then compared these specimens with collected tissue samples. Results: In 163 prospectively enrolled cases, nucleic acid extraction and analysis accuracy was 100% in cases diagnosed with adenocarcinoma. Gene mutations were found in 68.7% of cases with 99.5% (95% CI: 98.2\u201399.9) concordance to companion diagnostics. The median DNA\/RNA yield and DNA\/RNA integrity number were 475\/321 ng and 7.9\/5.7, respectively. The correlation coefficient of the gene allele ratio in 64 cases compared with tissue samples was 0.711. Conclusion: The success of gene analysis using cytological specimens was high, and the yield and quality of the extracted nucleic acid were sufficient for panel analysis. Moreover, the allele frequency of gene mutations in cytological specimens showed high correlations with tissue specimens.<\/jats:p>","DOI":"10.3390\/cancers14153784","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T20:52:01Z","timestamp":1659559921000},"page":"3784","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["A Prospective Validation Study of Lung Cancer Gene Panel Testing Using Cytological Specimens"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0745-5118","authenticated-orcid":false,"given":"Kei","family":"Morikawa","sequence":"first","affiliation":[{"name":"Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Kida","sequence":"additional","affiliation":[{"name":"Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Handa","sequence":"additional","affiliation":[{"name":"Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Inoue","sequence":"additional","affiliation":[{"name":"Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Saji","sequence":"additional","affiliation":[{"name":"Department of Chest Surgery, St. Marianna University School of Medicine, Kawasaki 216-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Pathological Diagnosis, St. Marianna University School of Medicine, Kawasaki 216-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Nakamura","sequence":"additional","affiliation":[{"name":"DNA Chip Research Inc., Tokyo 105-0022, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9984-7468","authenticated-orcid":false,"given":"Yoshiharu","family":"Sato","sequence":"additional","affiliation":[{"name":"DNA Chip Research Inc., Tokyo 105-0022, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Ueda","sequence":"additional","affiliation":[{"name":"DNA Chip Research Inc., Tokyo 105-0022, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"DNA Chip Research Inc., Tokyo 105-0022, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Matoba","sequence":"additional","affiliation":[{"name":"DNA Chip Research Inc., Tokyo 105-0022, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6933-6579","authenticated-orcid":false,"given":"Masamichi","family":"Mineshita","sequence":"additional","affiliation":[{"name":"Division of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gambardella, V., Tarazona, N., Cejalvo, J.M., Lombardi, P., Huerta, M., Rosell\u00f3, S., Fleitas, T., Roda, D., and Cervantes, A. (2020). Personalized Medicine: Recent Progress in Cancer Therapy. Cancers, 12.","DOI":"10.3390\/cancers12041009"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: A report from the ESMO Precision Medicine Working Group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_4","unstructured":"(2022, March 27). Summary of Safety and Effectiveness Data for Oncomine Dx Target Test, Available online: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/P160045B.pdf."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Murakami, S., Yokose, T., Nemoto, D., Suzuki, M., Usui, R., Nakahara, Y., Kondo, T., Kato, T., and Saito, H. (2021). Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing. Diagnostics, 11.","DOI":"10.20944\/preprints202101.0448.v1"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/resp.13823","article-title":"Is tissue still the issue in detecting molecular alterations in lung cancer?","volume":"25","author":"Liam","year":"2020","journal-title":"Respirology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1111\/cas.14112","article-title":"Small lung tumor biopsy samples are feasible for high quality targeted next generation sequencing","volume":"110","author":"Kage","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/cas.14489","article-title":"Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single-arm study","volume":"111","author":"Udagawa","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jtho.2021.06.017","article-title":"Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer","volume":"16","author":"Rolfo","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Hofman, P. (2021). Next-Generation Sequencing with Liquid Biopsies from Treatment-Na\u00efve Non-Small Cell Lung Carcinoma Patients. Cancers, 13.","DOI":"10.3390\/cancers13092049"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kato, K., Okami, J., Nakamura, H., Honma, K., Sato, Y., Nakamura, S., Kukita, Y., Nakatsuka, S., and Higashiyama, M. (2021). Analytical Performance of a Highly Sensitive System to Detect Gene Variants Using Next-Generation Sequencing for Lung Cancer Companion Diagnostics. medRxiv.","DOI":"10.1101\/2021.10.13.21264976"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Tsunoda, A., Morikawa, K., Inoue, T., Miyazawa, T., Hoshikawa, M., Takagi, M., and Mineshita, M. (2019). A prospective observational study to assess PD-L1 expression in small biopsy samples for non-small-cell lung cancer. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5773-3"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1158\/1078-0432.CCR-16-1631","article-title":"Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer","volume":"23","author":"Pelgrim","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"17588359211053420","DOI":"10.1177\/17588359211053420","article-title":"A case of advanced adenocarcinoma genetically confirmed with EGFR\/BRAF co-mutation in both primary and metastatic lesions","volume":"13","author":"Morikawa","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/dnares\/dsv010","article-title":"High-fidelity target sequencing of individual molecules identified using barcode sequences: De novo detection and absolute quantitation of mutations in plasma cell-free DNA from cancer patients","volume":"22","author":"Kukita","year":"2015","journal-title":"DNA Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Kunimasa, K., Kato, K., Imamura, F., and Kukita, Y. (2019). Quantitative detection of ALK fusion breakpoints in plasma cell-free DNA from patients with non-small cell lung cancer using PCR-based target sequencing with a tiling primer set and two-step mapping\/alignment. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0222233"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Kukita, Y., Ohkawa, K., Takada, R., Uehara, H., Katayama, K., and Kato, K. (2018). Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0192611"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Von Ahlfen, S., Missel, A., Bendrat, K., and Schlumpberger, M. (2007). Determinants of RNA Quality from FFPE Samples. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0001261"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1021\/bi00012a031","article-title":"Origins of the Large Differences in Stability of DNA and RNA Helixes: C-5 Methyl and 2\u2032-Hydroxyl Effects","volume":"34","author":"Wang","year":"1995","journal-title":"Biochemistry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2041-2223-4-7","article-title":"Long-term RNA persistence in postmortem contexts","volume":"4","author":"Fordyce","year":"2013","journal-title":"Investig. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35589","DOI":"10.1038\/srep35589","article-title":"Neoadjuvant Therapy in Rectal Cancer\u2014Biobanking of Preoperative Tumor Biopsies","volume":"6","author":"Jo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cllc.2021.09.002","article-title":"Genetic Profiling of Cell-Free DNA From Pleural Effusion in Advanced Lung Cancer as a Surrogate for Tumor Tissue and Revealed Additional Clinical Actionable Targets","volume":"23","author":"Tu","year":"2021","journal-title":"Clin. Lung Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"12510","DOI":"10.1038\/s41598-017-12679-8","article-title":"Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches","volume":"7","author":"Vendrell","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1016\/j.cllc.2019.05.001","article-title":"A Rare Fusion of CLIP1 and ALK in a Case of Non\u2013Small-Cell Lung Cancer With Neuroendocrine Features","volume":"20","author":"Pinsolle","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2017.12.018","article-title":"High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer","volume":"117","author":"Ariyasu","year":"2018","journal-title":"Lung Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/15384047.2016.1139235","article-title":"Compound EGFR mutation is frequently detected with co-mutations of actionable genes and associated with poor clinical outcome in lung adenocarcinoma","volume":"17","author":"Kim","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/LBR.0000000000000511","article-title":"The Safety and Utility of Fiberoptic Bronchoscopy in the Very Elderly","volume":"25","author":"McLaughlin","year":"2018","journal-title":"J. Bronchol. Interv. Pulmonol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/ggi.14313","article-title":"Flexible bronchoscopy for lung cancer diagnosis in patients aged \u2265 85\u2009years","volume":"22","author":"Mineshita","year":"2022","journal-title":"Geriatr. Gerontol. Int."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Morikawa, K., Kinoshita, K., Kida, H., Inoue, T., and Mineshita, M. (2022). Preliminary Results of NGS Gene Panel Test Using NSCLC Sputum Cytology and Therapeutic Effect Using Corresponding Molecular-Targeted Drugs. Genes, 13.","DOI":"10.3390\/genes13050812"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/1759-7714.13767","article-title":"Comparison of the analytical performance between the Oncomine Dx Target Test and a conventional single gene test for epidermal growth factor receptor mutation in non-small cell lung cancer","volume":"12","author":"Sakaguchi","year":"2021","journal-title":"Thorac. Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/15\/3784\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:03:49Z","timestamp":1760141029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/14\/15\/3784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":31,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["cancers14153784"],"URL":"https:\/\/doi.org\/10.3390\/cancers14153784","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}